Pancreatic cancer has a grim prognosis. It is usually detected after the disease has spread, and chemotherapy tends to do little to slow the cancer’s growth. Even with treatment, most patients live only about six months after they are diagnosed with the disease.
Researchers in Professor David Tuveson’s laboratory at Cold Spring Harbor Laboratory (CSHL) think it’s possible to do better with a different type of treatment. Part of the problem, they say, is that cancer cells in the pancreas are protected by the dense matrix that surrounds them. The matrix is a mixture of extracellular components and noncancerous cells known as the stroma. All solid tumors contain stroma. In pancreatic cancers, this fibrous material is particularly abundant, making up nearly 90 percent of a tumor’s mass. This stroma impedes anticancer drugs’ from getting to their targets. Additionally, stromal cells secrete factors that actually help the tumors grow.
Overcoming the stroma’s protective influence has been challenging, but new leads from Tuveson’s team, as reported on October 26, 2018 in the journal Cancer Discovery, point to a promising strategy. In fact, the new findings suggest that drugs which target the right cellular pathways can do more than just thwart tumor-supporting cells in the stroma. They may recruit them into the anticancer fight.
A key element of the stroma is a type of cell called a fibroblast. Fibroblasts manufacture the stroma’s connective tissue. They also generate factors that promote cancer cell growth and prevent the immune system from attacking the cancerous cells. Last year Tuveson’s team discovered that the stroma of pancreatic tumors contains at least two types of fibroblasts. One type show features known to support tumor growth, the other type appear to have the opposite effect.
The good news is that the fibroblasts’ identities are not fixed. With the right cues, tumor-promoting fibroblasts can become tumor-restrictors.
“These cells can convert into one another, depending on the cues they get from the microenvironment and from the cancer cells,” explains Giulia Biffi, a postdoctoral researcher in Tuveson’s lab who led the new study. “This is potentially useful because, in theory, you can shift the tumor-promoting cells to tumor-restraining, rather than just depleting the tumor-promoting cells.”
In this new report, Biffi and her colleagues have identified specific molecular signals released by cancer cells that determine fibroblasts’ character within pancreatic tumors. They have discovered that one such molecule, IL-1, drives fibroblasts to take on a tumor-promoting identity. They have also shown how another molecule, TGF-beta, overrides that signal and keeps fibroblasts in a potentially anticancer state even when IL-1 is present.
The researchers are now exploring what happens to pancreatic tumors when they manipulate IL-1 and TGF-beta signaling and convert tumor-promoting fibroblasts to a more beneficial state. They will also investigate what happens when they target these pathways in combination with chemotherapy or cancer immunotherapies. Ultimately, Biffi says, patients may benefit most from a combination of therapies that target both the cancer cells and parts of the microenvironment that support their growth.
Learn more: Turning cells against pancreatic cancer
The Latest on: Pancreatic cancer
via Google News
The Latest on: Pancreatic cancer
- Tom Watson's wife, Hilary Watson, dies of pancreatic canceron November 29, 2019 at 11:03 am
Hilary Watson, wife of eight-time major champion Tom Watson, died on Wednesday after a two-year battle with pancreatic cancer. She was 63. The Watsons originally got Hilary’s diagnosis in October 2017 ...
- Branched-chain amino acids sustain pancreatic cancer growth by regulating lipid metabolismon November 29, 2019 at 2:45 am
However, the precise roles of BCAA metabolism in cancer growth and survival remain largely unclear. Here, we found that BCAA metabolism has an important role in human pancreatic ductal adenocarcinoma ...
- Devoted wife raises funds for Pancreatic Cancer Research in memory of Beechwood husbandon November 29, 2019 at 2:31 am
A devoted wife organised a fundraiser in a bid to stop others suffering the heartache of pancreatic cancer in memory of her husband who died earlier this year aged just 59. The money raised from the ...
- Non-SMC condensin I complex subunit H mediates mature chromosome condensation and DNA damage in pancreatic cancer cellson November 29, 2019 at 2:20 am
However, the mechanisms through which NCAPH affects pancreatic cancer (PC) and its molecular function remain unclear. In this study, we examined the role of NCAPH in PC cells. Our results showed that ...
- Golfer Tom Watson's Wife Hilary Dies at 63 from Pancreatic Canceron November 28, 2019 at 12:57 pm
Hilary Watson, the wife of golfer Tom Watson, has died from pancreatic cancer at the age of 63. Barry Hyde, the agent of the eight-time major winner, confirmed she died on Wednesday, two years after ...
- Advances in Health: New Hope for Pancreatic Cancer Patientson November 28, 2019 at 5:00 am
(WTNH)– The pancreas is an important organ nestled deep in the abdomen that aids in digestion and regulates blood sugar levels. Cancer of the pancreas is an especially frightening form of cancer. Not ...
- Pancreatic cancer survivor says diagnosis doesn't have to be a death sentence, but research is keyon November 28, 2019 at 2:03 am
ATLANTA — It's a rare form of cancer that's been getting a lot of attention lately. This year an estimated 56,000 Americans will be diagnosed with pancreatic cancer. Nearly 46,000 of them will die.
- "Extraordinary responders" could hold clues to helping others with pancreatic canceron November 26, 2019 at 8:44 pm
New York — It's estimated that more than 56,000 Americans will be diagnosed with pancreatic cancer this year and nearly 46,000 will die from it. Supreme Court Justice Ruth Bader Ginsburg and "Jeopardy ...
- Newly developed personalized vaccine system could delay onset of pancreatic canceron November 26, 2019 at 10:44 am
Researchers from Queen Mary University of London and Zhengzhou University have developed a personalized vaccine system that could ultimately delay the onset of pancreatic cancer. The study provides ...
via Bing News